| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | ZINC_FINGER_C2H2_1 | ZNF438 ZNF134 TUT4 ZEB1 ADNP2 ZNF521 ZNF343 SALL4 ZNF217 GPATCH8 ZNF786 ZIC1 ZIC2 ZNF469 ZNF684 ZBTB40 ZNF770 ZNF639 | 6.60e-06 | 777 | 129 | 18 | PS00028 |
| Domain | Znf_C2H2-like | ZNF438 ZNF134 ZEB1 RNF166 ADNP2 ZNF521 ZNF343 SALL4 ZNF217 GPATCH8 ZNF786 ZIC1 ZIC2 ZNF469 ZNF684 ZBTB40 ZNF770 ZNF639 | 9.18e-06 | 796 | 129 | 18 | IPR015880 |
| Domain | Znf_C2H2 | ZNF438 ZNF134 ZEB1 RNF166 ADNP2 ZNF521 ZNF343 SALL4 ZNF217 GPATCH8 ZNF786 ZIC1 ZIC2 ZNF469 ZNF684 ZBTB40 ZNF770 ZNF639 | 1.07e-05 | 805 | 129 | 18 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF438 ZNF134 ZEB1 RNF166 ADNP2 ZNF521 ZNF343 SALL4 ZNF217 GPATCH8 ZNF786 ZIC1 ZIC2 ZNF469 ZNF684 ZBTB40 ZNF770 ZNF639 | 1.12e-05 | 808 | 129 | 18 | SM00355 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF438 ZNF134 ZEB1 ADNP2 ZNF521 ZNF343 SALL4 ZNF217 GPATCH8 ZNF786 ZIC1 ZIC2 ZNF469 ZNF684 ZBTB40 ZNF770 ZNF639 | 2.45e-05 | 775 | 129 | 17 | PS50157 |
| Domain | Chemokine_CXC_CS | 8.75e-05 | 13 | 129 | 3 | IPR018048 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF438 ZNF134 ZEB1 ZNF521 ZNF343 SALL4 ZNF217 ZNF786 ZIC1 ZIC2 ZNF469 ZNF684 ZBTB40 ZNF770 ZNF639 | 9.01e-05 | 694 | 129 | 15 | IPR013087 |
| Domain | CXC_Chemokine_domain | 1.11e-04 | 14 | 129 | 3 | IPR033899 | |
| Domain | Chemokine_CXC | 1.69e-04 | 16 | 129 | 3 | IPR001089 | |
| Domain | SMALL_CYTOKINES_CXC | 2.04e-04 | 17 | 129 | 3 | PS00471 | |
| Domain | - | ZNF438 ZNF134 ZEB1 ZNF521 ZNF343 SALL4 ZNF217 ZNF786 ZIC1 ZIC2 ZNF684 ZBTB40 ZNF770 ZNF639 | 2.54e-04 | 679 | 129 | 14 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF438 ZNF134 ZNF521 ZNF343 SALL4 ZNF217 ZNF786 ZIC1 ZIC2 ZNF469 ZNF684 ZBTB40 ZNF770 ZNF639 | 3.13e-04 | 693 | 129 | 14 | PF00096 |
| Domain | AWS | 4.67e-04 | 5 | 129 | 2 | SM00570 | |
| Domain | AWS | 4.67e-04 | 5 | 129 | 2 | PS51215 | |
| Domain | AWS_dom | 4.67e-04 | 5 | 129 | 2 | IPR006560 | |
| Domain | zf-Di19 | 9.72e-04 | 7 | 129 | 2 | PF05605 | |
| Domain | Di19_Zn_binding_dom | 9.72e-04 | 7 | 129 | 2 | IPR008598 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCAPD3 ZEB1 RBBP8 AAK1 DIDO1 ZNF217 NIBAN2 GPATCH8 RFX7 KANSL2 DBF4 ASPH MKI67 ZBTB40 SMARCC2 UNK YY1AP1 CXADR | 1.55e-09 | 774 | 136 | 18 | 15302935 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NSD2 LIN54 WRN ADNP2 NVL DIDO1 GPATCH8 SETDB2 RNF220 SBNO1 MKI67 ZBTB40 PINX1 SMARCC2 ZNF770 | 1.81e-08 | 608 | 136 | 15 | 36089195 |
| Pubmed | UNC13B PPRC1 TTLL5 ASH1L ADNP2 RAP1GAP2 ZNF521 ZNF343 SPOCK2 ADAMTS8 TTC3 CEP350 RNF220 KANSL2 CS SACS SBNO1 ASTN2 YY1AP1 ANKRD36 KLHL4 | 3.03e-08 | 1285 | 136 | 21 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAF1 DENND4A AAK1 RFX7 ARHGEF17 CEP350 STOX2 PANK2 CASKIN2 ISCU EIF5 DOCK7 PEAK1 MAPK4 TRAPPC9 DOP1A | 2.85e-07 | 861 | 136 | 16 | 36931259 |
| Pubmed | Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS. | 1.87e-06 | 23 | 136 | 4 | 24360543 | |
| Pubmed | Zic2 patterns binocular vision by specifying the uncrossed retinal projection. | 2.02e-06 | 7 | 136 | 3 | 13678579 | |
| Pubmed | 4.83e-06 | 9 | 136 | 3 | 10714680 | ||
| Pubmed | 6.48e-06 | 31 | 136 | 4 | 36476860 | ||
| Pubmed | 6.67e-06 | 116 | 136 | 6 | 30804394 | ||
| Pubmed | 6.88e-06 | 10 | 136 | 3 | 9730606 | ||
| Pubmed | 6.88e-06 | 10 | 136 | 3 | 28215559 | ||
| Pubmed | SART3 DENND4A CALD1 SPOCK1 PPRC1 RBBP8 NSD2 LIN54 ASH1L DNAH2 ANKRD30B TTC3 SACS SBNO1 FAM161A SMARCC2 DOP1A BAHCC1 | 1.39e-05 | 1442 | 136 | 18 | 35575683 | |
| Pubmed | Medial epithelial seam cell migration during palatal fusion. | 1.52e-05 | 2 | 136 | 2 | 31264714 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 21791114 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24904089 | ||
| Pubmed | Transcription factors Zic1 and Zic2 bind and transactivate the apolipoprotein E gene promoter. | 1.52e-05 | 2 | 136 | 2 | 11038359 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 27007163 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 21705622 | ||
| Pubmed | Zic-Proteins Are Repressors of Dopaminergic Forebrain Fate in Mice and C. elegans. | 1.52e-05 | 2 | 136 | 2 | 28972122 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24858828 | ||
| Pubmed | CXCL5 secreted from macrophages during cold exposure mediates white adipose tissue browning. | 1.52e-05 | 2 | 136 | 2 | 34537202 | |
| Pubmed | Role of CXCL5 in leukocyte recruitment to the lungs during secondhand smoke exposure. | 1.52e-05 | 2 | 136 | 2 | 22362385 | |
| Pubmed | CXCL5 inhibits excessive oxidative stress by regulating white adipocyte differentiation. | 1.52e-05 | 2 | 136 | 2 | 35696764 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 11427728 | ||
| Pubmed | Cloning and characterization of the human granulocyte chemotactic protein-2 gene. | 1.52e-05 | 2 | 136 | 2 | 9164944 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 33045777 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 20144627 | ||
| Pubmed | Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis. | 1.52e-05 | 2 | 136 | 2 | 15467832 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 37138312 | ||
| Pubmed | Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer. | 1.52e-05 | 2 | 136 | 2 | 26297948 | |
| Pubmed | Mutating novel interaction sites in NRP1 reduces SARS-CoV-2 spike protein internalization. | 1.52e-05 | 2 | 136 | 2 | 36910328 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 32495170 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 11699604 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 23975892 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 12468547 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 29119707 | ||
| Pubmed | CXCL5 is required for angiogenesis, but not structural adaptation after small bowel resection. | 1.52e-05 | 2 | 136 | 2 | 24888846 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 32651741 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 37942533 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 11239433 | ||
| Pubmed | LIX: a chemokine with a role in hematopoietic stem cells maintenance. | 1.52e-05 | 2 | 136 | 2 | 15036238 | |
| Pubmed | Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone. | 1.52e-05 | 2 | 136 | 2 | 29202471 | |
| Pubmed | Regulation of chromatin accessibility and Zic binding at enhancers in the developing cerebellum. | 1.52e-05 | 2 | 136 | 2 | 25849986 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 34868067 | ||
| Pubmed | 2.06e-05 | 14 | 136 | 3 | 21525298 | ||
| Pubmed | 2.06e-05 | 14 | 136 | 3 | 35231638 | ||
| Pubmed | 2.06e-05 | 14 | 136 | 3 | 7622488 | ||
| Pubmed | Parcellation of the striatal complex into dorsal and ventral districts. | 2.23e-05 | 42 | 136 | 4 | 32170006 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | TUT4 CALD1 DDX60 AAK1 NIBAN2 TTC3 CEP350 RRN3 EIF5 MKI67 DOCK7 UNK | 2.92e-05 | 724 | 136 | 12 | 36232890 |
| Pubmed | 3.16e-05 | 16 | 136 | 3 | 22632726 | ||
| Pubmed | 3.82e-05 | 17 | 136 | 3 | 22578469 | ||
| Pubmed | LPA5 receptor plays a role in pain sensitivity, emotional exploration and reversal learning. | 4.54e-05 | 3 | 136 | 2 | 23039190 | |
| Pubmed | Serine 58 of 14-3-3zeta is a molecular switch regulating ASK1 and oxidant stress-induced cell death. | 4.54e-05 | 3 | 136 | 2 | 19451227 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 39392048 | ||
| Pubmed | Expression of semaphorin 3A and its receptors during mouse corneal development. | 4.54e-05 | 3 | 136 | 2 | 21075075 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 22827607 | ||
| Pubmed | Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle induced bone loss. | 4.54e-05 | 3 | 136 | 2 | 26602825 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 31311916 | ||
| Pubmed | The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis. | 4.54e-05 | 3 | 136 | 2 | 31562303 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 28973351 | ||
| Pubmed | Apoptosis-linked gene-2 connects the Raf-1 and ASK1 signalings. | 4.54e-05 | 3 | 136 | 2 | 15925322 | |
| Pubmed | Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy. | 4.54e-05 | 3 | 136 | 2 | 18413205 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 15914641 | ||
| Pubmed | Granulocyte chemotactic protein-2 mediates adaptive immunity in part through IL-8Rbeta interactions. | 4.54e-05 | 3 | 136 | 2 | 15356099 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 14500350 | ||
| Pubmed | Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5. | 4.54e-05 | 3 | 136 | 2 | 30873585 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 24615544 | ||
| Pubmed | Increased serum CXCL1 and CXCL5 are linked to obesity, hyperglycemia, and impaired islet function. | 4.54e-05 | 3 | 136 | 2 | 24928936 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 22024047 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 12077361 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 30559223 | ||
| Pubmed | Differential expression of semaphorin 3A and its receptors during mouse retinal development. | 4.54e-05 | 3 | 136 | 2 | 22505034 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 37201403 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 14679585 | ||
| Pubmed | Overlapping and distinct expression domains of Zic2 and Zic3 during mouse gastrulation. | 4.54e-05 | 3 | 136 | 2 | 15261827 | |
| Pubmed | The mouse zic gene family. Homologues of the Drosophila pair-rule gene odd-paired. | 4.54e-05 | 3 | 136 | 2 | 8557628 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 34636164 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 28970523 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 20471049 | ||
| Pubmed | Zic2 regulates the expression of Sert to modulate eye-specific refinement at the visual targets. | 4.54e-05 | 3 | 136 | 2 | 20676059 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 12950257 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 34653642 | ||
| Pubmed | Expression of ZIC family genes in meningiomas and other brain tumors. | 4.54e-05 | 3 | 136 | 2 | 20199689 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 29755127 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 17878384 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 24509076 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 38627393 | ||
| Pubmed | CXCL5/CXCR2 modulates inflammation-mediated neural repair after optic nerve injury. | 4.54e-05 | 3 | 136 | 2 | 33785307 | |
| Pubmed | PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. | 5.41e-05 | 19 | 136 | 3 | 15239958 | |
| Pubmed | 5.81e-05 | 170 | 136 | 6 | 15057823 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.24e-05 | 341 | 136 | 8 | 32971831 | |
| Pubmed | VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm. | 6.35e-05 | 20 | 136 | 3 | 21658587 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 6.66e-05 | 444 | 136 | 9 | 34795231 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | SART3 TUT4 ZEB1 NSD2 LIN54 DIDO1 TTC3 RNF220 KANSL2 CASKIN2 EIF5 PINX1 SLC29A1 | 7.31e-05 | 925 | 136 | 13 | 28986522 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 7.63e-05 | 351 | 136 | 8 | 38297188 | |
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 11053430 | ||
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 25024172 | ||
| Pubmed | Involvement of Fes/Fps tyrosine kinase in semaphorin3A signaling. | 9.06e-05 | 4 | 136 | 2 | 12093729 | |
| Pubmed | CXCL5 limits macrophage foam cell formation in atherosclerosis. | 9.06e-05 | 4 | 136 | 2 | 23376791 | |
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 15778492 | ||
| Interaction | H3-3A interactions | NSD2 LIN54 ASH1L WRN ADNP2 NVL DIDO1 NIBAN2 GPATCH8 SETDB2 RNF220 SBNO1 EIF5 MKI67 ZBTB40 PINX1 SMARCC2 ZNF770 | 2.69e-06 | 749 | 135 | 18 | int:H3-3A |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF438 ZNF134 ZEB1 ADNP2 ZNF521 ZNF343 SALL4 ZNF217 ZNF786 ZIC1 ZIC2 ZNF469 ZNF684 ZBTB40 ZNF770 ZNF639 | 3.82e-07 | 718 | 89 | 16 | 28 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 6.18e-04 | 34 | 89 | 3 | 487 | |
| GeneFamily | SPARC family | 6.58e-04 | 8 | 89 | 2 | 1278 | |
| GeneFamily | Chemokine ligands|Endogenous ligands | 1.41e-03 | 45 | 89 | 3 | 483 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.41e-03 | 15 | 89 | 2 | 529 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | KIF18A NCAPD3 CALD1 PPRC1 RBBP8 NSD2 DDX60 WRN ADNP2 IFIT3 ZIC2 FRRS1 KANSL2 CS EFNB2 SACS RRN3 DBF4 CXCL9 MKI67 DOCK7 PINX1 PLXNA1 KNL1 | 2.44e-07 | 1407 | 136 | 24 | M14427 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | SART3 TUT4 PPRC1 DIDO1 ZNF217 MAP3K5 CEP350 EFNB2 SACS MKI67 DOP1A | 5.04e-07 | 300 | 136 | 11 | M8702 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.72e-06 | 180 | 136 | 8 | M8239 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN | 5.33e-06 | 183 | 136 | 8 | M4289 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SYCP2L TUT4 SPOCK1 LIN54 RAP1GAP2 SPOCK2 SALL4 RFX7 TTC3 STOX2 SMARCC2 ANKRD36 CXCL5 MUC2 PLXNA1 CXADR CCDC144A DOP1A | 1.73e-05 | 1106 | 136 | 18 | M39071 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 3.20e-05 | 305 | 136 | 9 | M19875 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | UNC13B KIF18A NCAPD3 DENND4A RBBP8 TTLL5 NVL SALL4 ZNF217 GPATCH8 DDB2 MAP3K5 SETDB2 DBF4 PLCG2 CPLANE1 DOP1A | 1.34e-05 | 820 | 132 | 17 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | Control-T/NK_proliferative|World / Disease group and Cell class | 9.05e-07 | 169 | 136 | 7 | fca735cbb55fce4d32dc6632a39acea1d16b87ab | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.27e-06 | 194 | 136 | 7 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 195 | 136 | 7 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 195 | 136 | 7 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 195 | 136 | 7 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 164 | 136 | 6 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-05 | 165 | 136 | 6 | 9d2bdc42c13c8c2a68889bec8612a1ce56f659fa | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.44e-05 | 171 | 136 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 175 | 136 | 6 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | Dividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.64e-05 | 175 | 136 | 6 | 0a8bf455babb3271aa00642199fb58b0b02dc3ac | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 175 | 136 | 6 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.70e-05 | 176 | 136 | 6 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-05 | 178 | 136 | 6 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.87e-05 | 179 | 136 | 6 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 180 | 136 | 6 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 181 | 136 | 6 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.99e-05 | 181 | 136 | 6 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.99e-05 | 181 | 136 | 6 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 181 | 136 | 6 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 2.05e-05 | 182 | 136 | 6 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.05e-05 | 182 | 136 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 2.12e-05 | 183 | 136 | 6 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 186 | 136 | 6 | ca5e9c6531cb5d199e27509bfab1d62e3937177e | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 186 | 136 | 6 | 1ed71b229f40a680071b14f5a7a19706e0fd14b1 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.32e-05 | 186 | 136 | 6 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.32e-05 | 186 | 136 | 6 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 187 | 136 | 6 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.39e-05 | 187 | 136 | 6 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.46e-05 | 188 | 136 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 188 | 136 | 6 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 2.46e-05 | 188 | 136 | 6 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-05 | 188 | 136 | 6 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 2.54e-05 | 189 | 136 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-05 | 189 | 136 | 6 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-05 | 189 | 136 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 190 | 136 | 6 | 1ab3f19f1ce9f58e5125135704d94655a2e330a0 | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 2.69e-05 | 191 | 136 | 6 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.69e-05 | 191 | 136 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 2.69e-05 | 191 | 136 | 6 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 2.69e-05 | 191 | 136 | 6 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 2.77e-05 | 192 | 136 | 6 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.77e-05 | 192 | 136 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 192 | 136 | 6 | 6806a1a9fe00395dc1abc3e0124b4261dc701f31 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.85e-05 | 193 | 136 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Control-B_naive-4|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.87e-05 | 116 | 136 | 5 | 35d471c8dbf408d0be3837c428d9c2a73c805a6f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-05 | 194 | 136 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-05 | 194 | 136 | 6 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 2.94e-05 | 194 | 136 | 6 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.02e-05 | 195 | 136 | 6 | 6a0460d949ccda7c9fe76870d3ee6c2f60677d61 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.02e-05 | 195 | 136 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.11e-05 | 196 | 136 | 6 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-05 | 196 | 136 | 6 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.11e-05 | 196 | 136 | 6 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.11e-05 | 196 | 136 | 6 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-05 | 196 | 136 | 6 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 196 | 136 | 6 | 5ddd314d3def3776dc7da83778d41c6436ca51ac | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 3.11e-05 | 196 | 136 | 6 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.11e-05 | 196 | 136 | 6 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-05 | 197 | 136 | 6 | 4edf043e8f586fd375f56485841fe992a18bf853 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.20e-05 | 197 | 136 | 6 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-05 | 197 | 136 | 6 | a41420d4b6d502c2f594c054c7efbb5d4eac83ff | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 197 | 136 | 6 | 9b2c67de46bd59bf56c81a0d10b84cf4a041c120 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 197 | 136 | 6 | f84f0ddf51208764ab56408d97035bbff562e59d | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-05 | 197 | 136 | 6 | 1c89d6836eed30c50c765f7dde9cc8ee15c363d2 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 197 | 136 | 6 | a0d463825b62de49466f9fa563405dda4387cfff | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.29e-05 | 198 | 136 | 6 | 63f7d25201613bd3404c28fb936954190bca91d3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.29e-05 | 198 | 136 | 6 | a73534b6ca202c277a70a52281d5b97a3e6cb8ef | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.29e-05 | 198 | 136 | 6 | d1e1bdd36c84e1bac21ba137f018defe98456a8c | |
| ToppCell | distal-mesenchymal-Myofibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.29e-05 | 198 | 136 | 6 | beef5075ba6dcd4d0a447bc4e57efcaf2e93c546 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.29e-05 | 198 | 136 | 6 | c9c96066c7fa897b583657f0b77ea093920ae9ba | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.29e-05 | 198 | 136 | 6 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-05 | 198 | 136 | 6 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 3.39e-05 | 199 | 136 | 6 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 3.39e-05 | 199 | 136 | 6 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-05 | 199 | 136 | 6 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.39e-05 | 199 | 136 | 6 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 3.39e-05 | 199 | 136 | 6 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 3.39e-05 | 199 | 136 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.39e-05 | 199 | 136 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.39e-05 | 199 | 136 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | 3.39e-05 | 199 | 136 | 6 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-05 | 200 | 136 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-05 | 200 | 136 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.48e-05 | 200 | 136 | 6 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 3.48e-05 | 200 | 136 | 6 | 4556bb626ca1a00a6db13d2adb35acb8ba848f9c | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-hematologic-erythrocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.27e-05 | 126 | 136 | 5 | cd02f3d4a3fadd24f3a298639b392f0354d227d2 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-hematologic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.27e-05 | 126 | 136 | 5 | f2ec5aa6c649ae1ff99519f6897cf207dc292edf | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.27e-05 | 126 | 136 | 5 | 61a7e400cbc81691b21cd3c37376c1d19fec2270 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-05 | 127 | 136 | 5 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.93e-05 | 135 | 136 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| Disease | colon carcinoma (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:1520 (implicated_via_orthology) | |
| Disease | mucositis (biomarker_via_orthology) | 2.00e-04 | 5 | 133 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | neuropilin-1 measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0020603 | |
| Disease | severe acute respiratory syndrome (biomarker_via_orthology) | 5.55e-04 | 8 | 133 | 2 | DOID:2945 (biomarker_via_orthology) | |
| Disease | age-related macular degeneration, disease progression measurement | 8.42e-04 | 41 | 133 | 3 | EFO_0001365, EFO_0008336 | |
| Disease | response to methotrexate, serum alanine aminotransferase measurement | 9.68e-04 | 43 | 133 | 3 | EFO_0004735, GO_0031427 | |
| Disease | Barrett's esophagus (is_marker_for) | 1.08e-03 | 11 | 133 | 2 | DOID:9206 (is_marker_for) | |
| Disease | prostatitis (biomarker_via_orthology) | 1.29e-03 | 12 | 133 | 2 | DOID:14654 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 1.29e-03 | 12 | 133 | 2 | OBA_2045152 | |
| Disease | IGF-1 measurement | 1.71e-03 | 488 | 133 | 8 | EFO_0004627 | |
| Disease | PR interval | 1.87e-03 | 495 | 133 | 8 | EFO_0004462 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 2.32e-03 | 16 | 133 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Cardiomyopathies | 2.89e-03 | 130 | 133 | 4 | C0878544 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 2.94e-03 | 18 | 133 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | eye morphology measurement | 3.14e-03 | 218 | 133 | 5 | EFO_0007858 | |
| Disease | mean reticulocyte volume | PPRC1 MARCHF8 DNAH2 ZNF217 CEP350 ZNF469 B3GNT2 ZBTB40 SLC29A1 TRAPPC9 | 3.41e-03 | 799 | 133 | 10 | EFO_0010701 |
| Disease | diastolic blood pressure, systolic blood pressure | 3.42e-03 | 670 | 133 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | Malignant neoplasm of breast | ZNF438 RAF1 ZEB1 NSD2 TTC3 SBNO1 CXCL9 EIF5 MKI67 ASTN2 ENPEP DOP1A | 3.45e-03 | 1074 | 133 | 12 | C0006142 |
| Disease | schizophrenia (implicated_via_orthology) | 3.62e-03 | 68 | 133 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | corneal hysteresis | 3.63e-03 | 20 | 133 | 2 | EFO_0010066 | |
| Disease | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | 3.93e-03 | 70 | 133 | 3 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517 | |
| Disease | palmitoylcarnitine measurement | 4.00e-03 | 21 | 133 | 2 | EFO_0021044 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 4.00e-03 | 21 | 133 | 2 | OBA_2045156 | |
| Disease | ulcerative colitis | 4.21e-03 | 335 | 133 | 6 | EFO_0000729 | |
| Disease | Autosomal Recessive Primary Microcephaly | 4.39e-03 | 22 | 133 | 2 | C3711387 | |
| Disease | Primary microcephaly | 4.39e-03 | 22 | 133 | 2 | C0431350 | |
| Disease | hemoglobin measurement, mean corpuscular hemoglobin | 4.39e-03 | 22 | 133 | 2 | EFO_0004509, EFO_0004527 | |
| Disease | migraine disorder, endometriosis | 4.42e-03 | 73 | 133 | 3 | EFO_0001065, MONDO_0005277 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LCPLQDKAPRDLKAS | 376 | Q9P281 | |
| EKNEHCPSKRDPSKL | 131 | Q9NR48 | |
| SFKCEPEPRKSNFEK | 81 | Q5JVX7 | |
| PQQFPKKLKEEHDKC | 426 | Q5CZ79 | |
| KAESPDKDGLLKPTC | 641 | Q9BXX2 | |
| KCSPDNKPSLQIKEE | 566 | Q99708 | |
| SFKLLKKECPIPNVQ | 311 | Q2M2I8 | |
| FKLKPEDPKLCTDVN | 151 | Q9UHX3 | |
| APAENLIKSDSPCFK | 21 | Q8N6M5 | |
| NKALKPEDAKPCESQ | 871 | Q9UP79 | |
| KDPDKDSTPATCLKI | 161 | Q14330 | |
| CKAELDLQTEPPFSK | 386 | Q5JWR5 | |
| PKQPALKAICDKEDS | 1126 | A6QL64 | |
| CKGAPKTCTLLEKFP | 641 | Q12797 | |
| QAKECEKSPFLSLSP | 101 | Q8N7U9 | |
| KNLKVDDKCPSVSPS | 156 | Q8IYA2 | |
| TKEEPKCQKPRSLAA | 1891 | Q96M86 | |
| SLKTDNRPEKSKCKP | 31 | Q9UBU7 | |
| CLDPEAPFLKKVIQK | 91 | P80162 | |
| VCEGPKCLKPDSKFN | 756 | O75129 | |
| RKKPGPALAFEEKCS | 701 | Q5T6C5 | |
| KLEPEKLAACAPFLK | 726 | Q6IQ32 | |
| ACDDKLNKKSPPLVK | 1231 | Q7Z401 | |
| PCPGSKKQLKFEELQ | 111 | Q969G9 | |
| ASPDLSKLYKNCPKA | 566 | P04049 | |
| FFLDLSCEKSNPKKP | 186 | O15381 | |
| KNTDIAKELCLPPVK | 121 | Q9H1K1 | |
| IPFLLKKLAPTCKSE | 501 | Q96TA1 | |
| KKLAPTCKSELPRFQ | 506 | Q96TA1 | |
| SKSCLDPEFLKAIPI | 1476 | Q96PE2 | |
| CLDRNPEAFKPKIGK | 571 | Q6MZP7 | |
| PAAVKKPSFCIADIL | 36 | Q14774 | |
| ALKLCTKPEDLPDNK | 546 | P31152 | |
| IKSSKCKLPEQESLP | 776 | Q8NI77 | |
| KIEPSPLKENTLKSC | 626 | Q5HYC2 | |
| CFLEKKPSPIKDSSN | 436 | Q8IY21 | |
| IKKENTPLLNCAKPD | 91 | P52799 | |
| LPATRKPNKKCEESG | 1151 | Q9UKJ3 | |
| KNRVKPPKESALCLF | 346 | Q9UIW2 | |
| ILKPGDFKSDPKNNC | 5006 | Q02817 | |
| ECKNCFKPKSLHQLP | 16 | Q9H792 | |
| KKKSAPAEEQLRGPC | 251 | Q96BK5 | |
| SDKKIPAKKESCPNT | 196 | O96028 | |
| CLQEFKEKKLVPATP | 71 | Q96JB8 | |
| EVKKSFLGPLSPSCK | 81 | Q8N8W4 | |
| CPETSKKNIFEKSPL | 241 | Q5T0T0 | |
| KRLKTGKCSAFPDVP | 246 | Q8NG31 | |
| LKCIPASKKTDPQKD | 386 | Q9UQ07 | |
| DARKSFPCFDEPNKK | 226 | Q07075 | |
| AKVACKSSQPDPDKN | 1611 | P46013 | |
| YCKPTSKTKDNLENP | 936 | P16885 | |
| SPLELEPEAKKLCAK | 26 | Q92466 | |
| PCLVNKAKKTPLDLA | 141 | Q8WXE0 | |
| TPKSVPEKNLFKEAC | 106 | Q9C0H6 | |
| NCSEKKPLPFLAASI | 556 | Q8IZQ8 | |
| TIPGKCKNQEDPFEK | 761 | Q68CR7 | |
| PADSEKCQKLPFDLK | 366 | Q9BZ23 | |
| QEDCAKPADLDKKNP | 806 | O14786 | |
| LAAICPDCFKPAKNK | 226 | Q3MIT2 | |
| KLCTFILKNPPENSD | 136 | P55010 | |
| SNPVDKCKLDPNKAY | 1896 | Q96N67 | |
| KSFEKKLAPEECFSP | 106 | O75319 | |
| FIKCPFPKLDLVLSK | 611 | Q9H799 | |
| KKFCIRSPLNCDPEK | 201 | Q6ZNA5 | |
| GKAEKPTLEPCSKAA | 561 | Q9NY28 | |
| SDFKIKCEPKEGSLP | 156 | P78310 | |
| FSIPECQKLLPKAKG | 96 | O75390 | |
| KVCFEKALEEKPNNP | 156 | O14879 | |
| SPSVPSCKENEKKLN | 1551 | Q5VT06 | |
| QSEKKPSKYPLCSAD | 1236 | Q9BTC0 | |
| ECEVKKAPEKPLTSF | 321 | Q86TE4 | |
| ANCFSKLAKPPTICK | 56 | A6NNW6 | |
| NCFALIPKAPKKDVI | 396 | Q5JVL4 | |
| KPDFCSLLFKDPKLA | 446 | Q99518 | |
| APKPEKKDGVSFCAE | 76 | Q9H9L4 | |
| LKDLKQFAPSPSCEK | 46 | Q07325 | |
| SPELAGSCKFDKPKE | 5771 | Q8NDH2 | |
| EKRICLPKFQEKSPN | 6166 | Q8NDH2 | |
| KNLKVDDKCPSVSPS | 156 | A2RUR9 | |
| SCKEKCIAKAPTPLE | 586 | P82279 | |
| KSPKLLTVCKPFDLH | 446 | Q3B820 | |
| AFKKDNCKELVPLPE | 2266 | Q9P225 | |
| FVSPCVDKSKNPDFK | 776 | Q15020 | |
| EFLEHKKNCTKNPPV | 86 | Q9UJQ4 | |
| NKKLPSDEPKSSCIL | 1746 | Q9NZJ4 | |
| NSSPRDSPCKENKIK | 691 | A3KN83 | |
| LEQFEKSEAKKECPP | 1176 | Q5VV67 | |
| CLDPEAPFLKKVIQK | 91 | P42830 | |
| TKGFPCLKKPEDSSA | 391 | Q9Y661 | |
| AKAFILKCFEPDPDK | 911 | Q99683 | |
| PFDPCVLKRSKKFID | 561 | Q9NYV6 | |
| KLPSVPQIAKAFCDD | 216 | Q684P5 | |
| DKDLPLKFCEFPQKT | 1286 | O60522 | |
| KQPNCSSLFKLKPLS | 506 | Q8N7P1 | |
| LALALKKCKPSLPAE | 61 | Q9BXJ8 | |
| KKCKPSLPAEAEGAA | 66 | Q9BXJ8 | |
| LCRLPFDPKKVDKAT | 71 | Q96A37 | |
| CELKPKNTEKEPYSN | 391 | Q5VWT5 | |
| QKSPSLAKEVPDLCF | 436 | Q5VXU9 | |
| NEELCPKKLLLPSSK | 1066 | Q14191 | |
| KKAAALFDSQAPICP | 211 | Q5VTB9 | |
| SLKPGFKDSPKCSQA | 66 | Q96P15 | |
| APLTKLPIKCFLDFK | 71 | Q8TAQ2 | |
| KPFKEFVEACLNKDP | 241 | O00506 | |
| NESKEPDPCLKSNKQ | 66 | Q96P63 | |
| PDPCLKSNKQKAGSL | 71 | Q96P63 | |
| CFGPKKVKPAEAETA | 416 | Q99808 | |
| LIDQPDKCAKKPFLL | 131 | Q9NY97 | |
| GLSDDKKPFKCFTPK | 626 | Q05682 | |
| LLPKFSLKEKPQCVQ | 226 | P42695 | |
| KSYKSFEKCLPPNLD | 131 | Q5T5D7 | |
| KTEKCPPKFSNNPKE | 456 | Q96T68 | |
| LPSNDTDCPQKKEGK | 41 | Q6P1L6 | |
| PPAKLCKILDKSQAL | 171 | Q9UID6 | |
| LPKEKFKALLQLDPC | 106 | Q96C74 | |
| APTLQRKSAKDCKDP | 211 | Q9P2F5 | |
| KDPLASTKPCFSDKT | 231 | Q8N431 | |
| KRPFNSENAKKAPDC | 726 | Q5T4T6 | |
| QAKPRSLKDPNCKLE | 6 | Q96K83 | |
| DQALDPSKDPCLKVK | 76 | Q08629 | |
| SANSPKPACEDVKAK | 1241 | P53804 | |
| LSKDFPAYCTKEKLP | 1156 | O14795 | |
| DSINKDPKLCTKSPR | 546 | Q2KHR2 | |
| PCDKCEKVFPSISKL | 476 | Q6IQ21 | |
| AKCSPDQELSFPKNK | 1711 | Q96JG9 | |
| EPLNLSCAKKEPQKD | 766 | P37275 | |
| LLPVCSLKAKNPQDK | 286 | Q9H869 | |
| KSCPAPNELDIKKRL | 756 | Q8N393 | |
| EPEQLANPKKSCNKT | 231 | Q15915 | |
| FCKPKPKSAFPAQSK | 771 | O75362 | |
| SGDKIPLLCVPFEKK | 171 | Q96Q05 | |
| DPSKRPTAAELLKCK | 321 | Q9UEW8 | |
| KSCKVNAANLPGPKD | 71 | Q5TAX3 | |
| NFKCQAKLKPHSLEP | 431 | Q9C0B0 | |
| INKSKQPSEDPKNCL | 21 | Q6ZQQ6 | |
| FCPPTKLDLNHKTKL | 361 | Q7Z4V0 | |
| HPSEKPFTCKEEQKN | 126 | P52741 | |
| PSLACDAPLDLKIKA | 371 | Q6EMB2 | |
| AKKKPGIFIPSCDED | 326 | Q92563 | |
| SASPDPAKKSFICKA | 726 | Q9NUA8 | |
| IDPEQLSNPKKSCNK | 261 | O95409 |